Anti-cancer drug fights immune reaction in some infants with Pompe disease Medical Xpress Immune modulation with rituximab (anti-CD20 monoclonal antibody), plus methotrexate and intravenous gamma globulin (IVIG) in infantile CRIM-negative Pompe patients has resulted in tolerance induction in the naïve setting or after early detection of an ... |
